570 related articles for article (PubMed ID: 10704339)
1. Phenotyping of Evi1, Evi11/Cb2, and Evi12 transformed leukemias isolated from a novel panel of cas-Br-M murine leukemia virus-infected mice.
Joosten M; Valk PJ; Vankan Y; de Both N; Löwenberg B; Delwel R
Virology; 2000 Mar; 268(2):308-18. PubMed ID: 10704339
[TBL] [Abstract][Full Text] [Related]
2. Mml1, a new common integration site in murine leukemia virus-induced promonocytic leukemias maps to mouse chromosome 10.
Koller R; Krall M; Mock B; Bies J; Nazarov V; Wolff L
Virology; 1996 Oct; 224(1):224-34. PubMed ID: 8862417
[TBL] [Abstract][Full Text] [Related]
3. Large-scale identification of novel potential disease loci in mouse leukemia applying an improved strategy for cloning common virus integration sites.
Joosten M; Vankan-Berkhoudt Y; Tas M; Lunghi M; Jenniskens Y; Parganas E; Valk PJ; Löwenberg B; van den Akker E; Delwel R
Oncogene; 2002 Oct; 21(47):7247-55. PubMed ID: 12370816
[TBL] [Abstract][Full Text] [Related]
4. Biological characterization and molecular cloning of murine C-type retroviruses derived from the TSZ complex from mainland China.
Bundy LM; Ru M; Zheng BF; Cheng L; Pattengale PK; Portis JL; Fan H
Virology; 1995 Oct; 212(2):367-82. PubMed ID: 7571406
[TBL] [Abstract][Full Text] [Related]
5. 10A1 MuLV induces a murine leukemia that expresses hematopoietic stem cell markers by a mechanism that includes fli-1 integration.
Ott DE; Keller J; Rein A
Virology; 1994 Dec; 205(2):563-8. PubMed ID: 7975258
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility and resistance to Moloney murine leukemia virus-induced promonocytic leukemia.
Nazarov V; Hilbert D; Wolff L
Virology; 1994 Dec; 205(2):479-85. PubMed ID: 7975249
[TBL] [Abstract][Full Text] [Related]
7. Retroviral insertions in Evi12, a novel common virus integration site upstream of Tra1/Grp94, frequently coincide with insertions in the gene encoding the peripheral cannabinoid receptor Cnr2.
Valk PJ; Vankan Y; Joosten M; Jenkins NA; Copeland NG; Löwenberg B; Delwel R
J Virol; 1999 May; 73(5):3595-602. PubMed ID: 10196250
[TBL] [Abstract][Full Text] [Related]
8. Leukemic predisposition of pSca-1/Cb2 transgenic mice.
Joosten M; Valk PJ; Jordà MA; Vankan-Berkhoudt Y; Verbakel S; van den Broek M; Beijen A; Löwenberg B; Delwel R
Exp Hematol; 2002 Feb; 30(2):142-9. PubMed ID: 11823049
[TBL] [Abstract][Full Text] [Related]
9. Expression and DNA rearrangement of proto-oncogenes in Cas-Br-E-induced non-T-, non-B-cell leukemias.
Bergeron D; Houde J; Poliquin L; Barbeau B; Rassart E
Leukemia; 1993 Jul; 7(7):954-62. PubMed ID: 8391616
[TBL] [Abstract][Full Text] [Related]
10. A model for mixed virus disease: co-infection with Moloney murine leukemia virus potentiates runting induced by polyomavirus (A2 strain) in Balb/c and NIH Swiss mice.
Atencio IA; Belli B; Hobbs M; Cheng SF; Villarreal LP; Fan H
Virology; 1995 Oct; 212(2):356-66. PubMed ID: 7571405
[TBL] [Abstract][Full Text] [Related]
11. Importance of receptor usage, Fli1 activation, and mouse strain for the stem cell specificity of 10A1 murine leukemia virus leukemogenicity.
Rodenburg M; Fischer M; Engelmann A; Harbers SO; Ziegler M; Löhler J; Stocking C
J Virol; 2007 Jan; 81(2):732-42. PubMed ID: 17079317
[TBL] [Abstract][Full Text] [Related]
12. Analysis of neoplasms induced by Cas-Br-M MuLV tumor extracts.
Holmes KL; Langdon WY; Fredrickson TN; Coffman RL; Hoffman PM; Hartley JW; Morse HC
J Immunol; 1986 Jul; 137(2):679-88. PubMed ID: 3014001
[TBL] [Abstract][Full Text] [Related]
13. F-MuLV acceleration of myelomonocytic tumorigenesis in SV40 large T antigen transgenic mice is accompanied by retroviral insertion at Fli1 and a novel locus, Fim4.
Kone J; Arroyo J; Savinelli T; Lin S; Boyd K; Wu Y; Nimmakayalu M; Copeland NG; Jenkins NA; Qumsiyeh M; Hu P; Prescott A; Wu H; Yang L; Roe B; Perkins AS
Leukemia; 2002 Sep; 16(9):1827-34. PubMed ID: 12200699
[TBL] [Abstract][Full Text] [Related]
14. Mutation of all Runx (AML1/core) sites in the enhancer of T-lymphomagenic SL3-3 murine leukemia virus unmasks a significant potential for myeloid leukemia induction and favors enhancer evolution toward induction of other disease patterns.
Sørensen KD; Quintanilla-Martinez L; Kunder S; Schmidt J; Pedersen FS
J Virol; 2004 Dec; 78(23):13216-31. PubMed ID: 15542674
[TBL] [Abstract][Full Text] [Related]
15. Histologic and cell surface antigen studies of hematopoietic tumors induced by Cas-Br-M murine leukemia virus.
Fredrickson TN; Langdon WY; Hoffman PM; Hartley JW; Morse HC
J Natl Cancer Inst; 1984 Feb; 72(2):447-54. PubMed ID: 6319793
[TBL] [Abstract][Full Text] [Related]
16. Insertional activation of myb by F-MuLV in SCID mice induces myeloid leukemia.
Haeri M; Li Y; Li Y; Li Q; Spaner DE; Ben-David Y
Int J Oncol; 2013 Jul; 43(1):169-76. PubMed ID: 23677281
[TBL] [Abstract][Full Text] [Related]
17. Genetic heterogeneity in acute myeloid leukemia: maximizing information flow from MuLV mutagenesis studies.
Largaespada DA
Leukemia; 2000 Jul; 14(7):1174-84. PubMed ID: 10914539
[TBL] [Abstract][Full Text] [Related]
18. Retroviral insertional activation of the EVI1 oncogene does not prevent G-CSF-induced maturation of the murine pluripotent myeloid cell line 32Dcl3.
Khanna-Gupta A; Lopingco MC; Savinelli T; Zibello T; Berliner N; Perkins AS
Oncogene; 1996 Feb; 12(3):563-9. PubMed ID: 8637713
[TBL] [Abstract][Full Text] [Related]
19. Substitution of feline leukemia virus long terminal repeat sequences into murine leukemia virus alters the pattern of insertional activation and identifies new common insertion sites.
Johnson C; Lobelle-Rich PA; Puetter A; Levy LS
J Virol; 2005 Jan; 79(1):57-66. PubMed ID: 15596801
[TBL] [Abstract][Full Text] [Related]
20. Ets and retroviruses - transduction and activation of members of the Ets oncogene family in viral oncogenesis.
Blair DG; Athanasiou M
Oncogene; 2000 Dec; 19(55):6472-81. PubMed ID: 11175363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
